WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared...

WEDNESDAY, Dec. 11, 2024 -- For patients undergoing liver resection, hypovolemic phlebotomy reduces perioperative red blood cell transfusions compared...

The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for...

TUESDAY, Dec. 17, 2024 -- Knowledge of the association between human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma (OPSCC) is poor...

FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...

FRIDAY, Dec. 20, 2024 -- For patients with advanced breast cancer and baseline clinical anxiety, cannabidiol (CBD) is safe and may reduce anxiety...

On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...

On December 18, 2024, the Food and Drug Administration approved ensartinib (Ensacove, Xcovery Holdings, Inc.) for adult patients with anaplastic...

FRIDAY, Dec. 13, 2024 -- The addition of camrelizumab to neoadjuvant chemotherapy improves pathological complete response for patients with early or...

FRIDAY, Dec. 20, 2024 -- Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with...